Our national healthcare system continues to change at a rapid pace with the proliferation of genomic research and the development of new medical devices aimed at the consumer marketplace. Someday, will we wear biosensors to monitor our vital signs? When you finally have your genome sequenced, who will own the data, and how will it be shared? What impact will this continuous stream of data and consumer technology have on our healthcare practitioners? These three speakers explore what may be on the horizon in healthcare innovation.
Josh Windmiller, CEO, ElectroZyme
Patrick Merel, CEO, Portable Genomics
Bob McClure, EAP Manager, Sharp Healthcare